Scott Lukens, MD
Orthopaedic Surgery · Grand Island, NENPI 1396038956
Payments from drug & device makers
Across 54 payments — averaging $58.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Conetic Solutions, Inc.$1K
- Johnson & Johnson$813
- Stryker$434
- Smith+Nephew$134
- Integra Lifesciences Corporation$79
- Medical Device Business Services, Inc.$70
- plus $321 from 13 others
What the payments were for
- Travel & lodging$65321%
- Food & beverage$1,29741%
- Education$1,20038%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Conetic Solutions, Inc. | 7 | $1,298 |
| Johnson & Johnson | 7 | $813 |
| Stryker | 10 | $434 |
| Smith+Nephew | 6 | $134 |
| Integra Lifesciences Corporation | 3 | $79 |
| Medical Device Business Services, Inc. | 3 | $70 |
| Heron Therapeutics, Inc. | 3 | $58 |
| Pacira Pharmaceuticals Incorporated | 3 | $43 |
| Zimmer Biomet | 2 | $37 |
| Kerecis Limited | 1 | $28 |
| Vericel Corporation | 1 | $24 |
| KCI USA, Inc. | 1 | $21 |
| Linvatec Corporation | 1 | $18 |
| Polynovo North America LLC | 1 | $18 |
| RSW Medical Company, Inc. | 1 | $17 |
| Sanara Medtech Inc. | 1 | $17 |
| Orthofix Medical, Inc. | 1 | $16 |
| Convatec Inc. | 1 | $13 |
| Novartis | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CORAIL$653
How this compares
$3,149 in reported general payments places this provider in the 50th percentile of 155 orthopaedic surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 43 | $440 |
| Tramadol Hcl | 66 | $302 |
| Cephalexin | 12 | $59 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Grand Island
- Todd SekundiakElkhorn$7.3M
- Heber CrockettKearney$4.2M
- Edward FehringerOmaha$2M
- John WrightKearney$1.2M
- Joshua UrbanOmaha$1.1M
- Sayfe JassimOmaha$460K
- Beau KildowOmaha$353K
- David HuebnerKearney$131K
- Matthew DilisioOmaha$58K
- Benjamin WoodheadLincoln$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.